Neo Medical secures CHF 10 million in strategic investment from Orthofix Medical.

Neo Medical, a Lausanne, Switzerland-based health manufacturer of a new generation of products for spinal surgery, announced raising a strategic capital investment of CHF 10M ($10.8M).

The deal was made with Orthofix Medical, an American medical device company focused on musculoskeletal healing products. The deal is part of partnership agreement under which Orthofix will also exclusively distribute Neo Medical’s disruptive value-based thoracolumbar procedure solutions to certain US accounts. Additionally, Orthofix is investing $10 million in Neo Medical to support the ongoing partnership, through a combination of a convertible term loan and equity investment.

Neo Medical, founded by CEO Vincent Lefauconnier and Jonas Larsson develops a new generation of controlled-fixation solutions designed for a more Functional Fusion in spinal surgery, respectful of patients' unique spinal conditions. With only five multi-functional instruments covering most spine indications in a universal approach, the unique proprietary features of Neo Medical solutions ensure an anatomically neutral, balanced, and stable spine load bearing, to achieve a Functional Fusion.